Hood River Capital Management LLC Grows Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

Hood River Capital Management LLC raised its stake in Select Medical Holdings Co. (NYSE:SEM) by 404.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,755,733 shares of the health services provider’s stock after purchasing an additional 1,407,902 shares during the quarter. Hood River Capital Management LLC owned about 1.36% of Select Medical worth $33,096,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the stock. LPL Financial LLC raised its stake in Select Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 31,441 shares of the health services provider’s stock valued at $593,000 after acquiring an additional 619 shares in the last quarter. Bank of Montreal Can raised its stake in shares of Select Medical by 4.5% in the 4th quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider’s stock worth $378,000 after buying an additional 867 shares in the last quarter. Sippican Capital Advisors lifted its holdings in shares of Select Medical by 7.3% in the fourth quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider’s stock valued at $252,000 after buying an additional 912 shares during the period. Sterling Capital Management LLC lifted its stake in Select Medical by 9.5% during the fourth quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider’s stock valued at $213,000 after purchasing an additional 978 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D lifted its position in shares of Select Medical by 2.2% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider’s stock valued at $1,069,000 after acquiring an additional 1,234 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of NYSE SEM opened at $15.89 on Wednesday. The business’s 50 day moving average is $17.16 and its two-hundred day moving average is $22.66. The company has a market cap of $2.05 billion, a P/E ratio of 9.63, a P/E/G ratio of 0.64 and a beta of 1.38. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a 12 month low of $14.99 and a 12 month high of $40.98.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, equities analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were paid a $0.0625 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.57%. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Analyst Upgrades and Downgrades

SEM has been the topic of several recent analyst reports. Mizuho initiated coverage on Select Medical in a research report on Wednesday, April 16th. They set an “outperform” rating and a $25.00 price target on the stock. Royal Bank of Canada reduced their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a report on Monday, February 24th. Benchmark raised shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research report on Monday, February 24th. UBS Group cut their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $26.80.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.